Roivant Sciences Ltd. (ROIVW)
NASDAQ: ROIVW
· Real-Time Price · USD
2.75
0.12 (4.56%)
At close: Jan 16, 2025, 10:00 PM
Roivant Sciences Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
PE Ratio | -8.58 | -8.64 | 12.62 | -9.22 | 20.91 | -13.85 | 0.44 | -7.39 | -6.56 | -40.75 | -4.05 |
PEG Ratio | -0.62 | 0.04 | -0.07 | 0.03 | -0.12 | 0.13 | -0.00 | -1.4 | -0.01 | 0.45 | n/a |
PS Ratio | 3.53K | 942.75 | 948.07 | 1.9K | 144.54 | 289.45 | 242.07 | 242.48 | 353.93 | 200.17 | 334.24 |
PB Ratio | 1.76 | 1.52 | 1.65 | 1.65 | 1.47 | 1.40 | 1.48 | 9.48 | 8.40 | 4.73 | 5.96 |
P/FCF Ratio | -36.79 | -41.16 | -40.89 | -31.69 | -41.12 | -76.96 | -42.65 | -45.74 | -30.57 | -30.32 | -25.55 |
P/OCF Ratio | -37.51 | -41.36 | -41.25 | -31.81 | -41.33 | -77.21 | -42.72 | -45.8 | -30.62 | -30.6 | -25.6 |
OCF/S Ratio | -94.19 | -22.8 | -22.98 | -59.62 | -3.5 | -3.75 | -5.67 | -5.29 | -11.56 | -6.54 | -13.05 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.07 | 0.08 | 0.08 | 0.52 | 0.54 | 0.42 | 0.50 |
Quick Ratio | 40.54 | 33.47 | 37.91 | 10.43 | 27.75 | 25.10 | 27.77 | 5.82 | 6.35 | 6.59 | 6.74 |
Current Ratio | 40.54 | 33.47 | 37.91 | 10.43 | 27.91 | 25.24 | 27.79 | 5.84 | 6.37 | 6.60 | 6.74 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
Interest Coverage | n/a | n/a | n/a | n/a | -8.97 | -37.07 | 535.88 | 29.90 | -31.02 | -27.31 | -33.19 |
Return on Equity | -0.05 | -0.04 | 0.03 | -0.04 | 0.02 | -0.03 | 0.84 | -0.32 | -0.32 | -0.03 | -0.37 |
Return on Assets | -0.04 | -0.04 | 0.03 | -0.04 | 0.01 | -0.02 | 0.70 | -0.15 | -0.14 | -0.01 | -0.16 |
Return on Invested Capital | -0.06 | -0.07 | -0.04 | -0.06 | -0.02 | -0.04 | 0.71 | 0.15 | -0.14 | -0.11 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.93 | 0.79 | 0.97 | 0.95 | 0.93 | 0.85 | 0.90 | 0.91 | 0.81 | 0.66 | 0.51 |
Net Profit Margin | -102.93 | -27.28 | 18.78 | -51.44 | 1.73 | -5.22 | 137.22 | -8.2 | -13.5 | -1.23 | -20.64 |
Pretax Profit Margin | -124.08 | -26.82 | -26 | -50.14 | 1.27 | -6.62 | 137.27 | -8.82 | -15.08 | -6.55 | -22.41 |
Operating Profit Margin | -131.3 | -37.64 | -30.43 | -76.36 | -2.18 | -9.19 | 136.27 | 7.45 | -12.78 | -8.55 | -16.44 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -130.79 | -26.64 | -30.1 | -50.14 | 1.60 | 176.74 | -8.37 | -8.39 | -14.32 | -5.96 | -17.91 |